NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Wed, 29 Apr · 10:52 IST

Q4FY26 Earnings Call Intimation

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹14470.00
prior close
₹14713.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.5+0.3+0.3+3.0+11.3+11.9+17.5+18.5+21.6+15.5+18.1+25.1
Up moveDown movePending
AI summary

Neuland Laboratories has informed the stock exchanges that it will announce its Q4 and full-year FY2026 results on May 12, 2026. Following the announcement, the company's management will host an earnings conference call for analysts and investors on the same day at 17:30 hrs IST. The results will also be published on the company's website. This is a routine procedural disclosure under SEBI's listing regulations and contains no actual financial figures.

Likely market impact

No direct impact on the stock or shareholders. Investors should watch the May 12 results and call for actual performance numbers, guidance, and management commentary that could move the stock.